Skip to main content
Log in

Treatment of ankylosing spondylitis with flurbiprofen or phenylbutazone

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Flurbiprofen (150–200 mg daily) and phenylbutazone (300–400 mg daily) were compared in the management of 27 patients with active ankylosing spondylitis. This was a parallel, double-blind, and randomized trial of 6 weeks duration. Both drugs were equally effective in the relief of pain and tenderness of the affected joints. Overall subjective improvement, assessed by the patient and the investigator at the end of the trial, favored phenylbutazone, but it did not reach a statistically significant level. The mean values of the endpoint parameters of spinal motion showed statistically significant improvement in both groups, except in the Schober test in the flurbiprofen group and chest expansion in the phenylbutazone group. Untoward effects characteristic of these drugs were found in a few patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baraclough, D. R. E., Lenagham, E. Muirden, K. D.: A comparison of flurbiprofen and aspirin in the treatment of rheumatoid arthritis. Med. J. Aust,2, 925 (1974)

    Google Scholar 

  2. Mena, H. R., Ehrlich, G. E., Giansiracusa, J. E., et al.: Response of osteoarthritis to ibuprofen or flurbiprofen. J. Int. Med. Res.4, 152 (1976)

    Google Scholar 

  3. Kellgren, J. H., Jeffry, M. R., Ball, J. (eds.): The epidemiology of chronic rheumatism, vol. 1, page 326. Oxford: Blackwell 1961

    Google Scholar 

  4. Keele, K. D.: The pain chart. Lancet1948 II, 6–8

    Google Scholar 

  5. Doersma, J. W.: Retardation of lumbar ossification by phenylbutazone. Scan. J. Rheumatology5, 60–64 (1976)

    Google Scholar 

  6. Dudley Hart, F.: Ankylosing spondylitis: a survery. Ann. Rheum. Dis.13, 186–189 (1954)

    Google Scholar 

  7. Calabro, J., Amonte, C. M.: Indomethacin in ankylosing spondylitis. Arth. Rheumatism.11, 56 (1968)

    Google Scholar 

  8. Hill, H. F. H., Hill, A. G. S.: Naproxen in ankylosing spondylitis. Scand. J. Rheumatology Suppl.2, 121 (1973)

    Google Scholar 

  9. Calin, A., Graham, R.: Double-blind cross-over trial of flurbiprofen and phenylbutazone in ankylosing spondylitis. Brit. J. Med.1974 II, 496

    Google Scholar 

  10. Sturrock, R. D., Dudley Hart, F.: Double-blind cross-over comparison of indomethacin, flurbiprofen and placebo in ankylosing spondylitis. Ann. Rheum. Dis.33, 129 (1974)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mena, H.R., Willkens, R.F. Treatment of ankylosing spondylitis with flurbiprofen or phenylbutazone. Eur J Clin Pharmacol 11, 263–266 (1977). https://doi.org/10.1007/BF00607674

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00607674

Key words

Navigation